688065.SH
Cathay Biotech, Inc.
SSE · Basic Materials · Chemicals · CN
CNY 37.43
+1.05%Oct 30, 2026, 09:11 UTC
Cathay Biotech reported third-quarter 2026 revenue of RMB 938 million, up 7.26% year over year, and attributable net profit of RMB 154 million, up 8.60%; for the first nine months, revenue was RMB 2.838 billion, up 11.51%, attributable net profit was RMB 527 million, up 16.93%, and adjusted attributable net profit was RMB 476 million, up 11.13%.
Source:Aug 24, 2026, 10:24 UTC
Shanxi Science and Technology Innovation City Investment Development Co., Ltd. announced plans to reduce its stake in Cathay Biotech by up to 2% via block trades between September 15 and December 14, 2026.
Source:Aug 19, 2026, 11:22 UTC
Cathay Biotech announced its first-half 2026 results with revenue of 1.900 billion yuan, up 13.73% year-on-year, and net profit attributable to shareholders of 373 million yuan, up 20.75%.
Source: